On the origin of serum CD26 and its altered concentration in cancer patients Oscar J. CorderoFrancisco J. SalgadoMontserrat Nogueira Perspectives 26 June 2009 Pages: 1723 - 1747
Treatment combinations targeting apoptosis to improve immunotherapy of melanoma Peter HerseyXu Dong Zhang Perspectives 24 June 2009 Pages: 1749 - 1759
Improvement of tumor targeting and antitumor activity by a disulphide bond stabilized diabody expressed in Escherichia coli Juanni LiuMing YangDongsheng Xiong Original Article 04 March 2009 Pages: 1761 - 1769
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack Marcin OkrojLeticia CorralesAnna M. Blom Original Article 04 March 2009 Pages: 1771 - 1780
Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect Tae-Young LeeYang-Hyun KimHaryoung Poo Original Article 18 March 2009 Pages: 1781 - 1794
Onconeural antibodies in sera from patients with various types of tumours Sissel Evy MonstadAnette KnudsenChristian A. Vedeler Original article 18 March 2009 Pages: 1795 - 1800
Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer Ichiya HonmaHiroshi KitamuraNoriyuki Sato Original article 18 March 2009 Pages: 1801 - 1807
TGF-β modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expression Maria Giovanna di BariM. E. Christine LutsiakHelen Sabzevari Original article 25 March 2009 Pages: 1809 - 1818
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma Amedeo AmedeiElena NiccolaiMario Milco D’Elios Original article 25 March 2009 Pages: 1819 - 1830
Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro Alban GervaisJean-Christophe EymardJacky Bernard Original article 28 March 2009 Pages: 1831 - 1841
Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients Takashi HattoriTakashi MineKiyotaka Okuno Original article 26 April 2009 Pages: 1843 - 1852
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells Andrés López-AlbaiteroSteve C. LeeRobert L. Ferris Original article 25 March 2009 Pages: 1853 - 1862
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells Andrés López-AlbaiteroSteve C. LeeRobert L. Ferris Erratum 18 June 2009 Pages: 1863 - 1864
Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene Taimei YangMichele L. MartinBrad H. Nelson Original Article 07 April 2009 Pages: 1865 - 1875
An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles Yasunobu TerasakiShigeki ShichijoKyogo Itoh Original article 28 March 2009 Pages: 1877 - 1885
Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing Timothy E. KuteLori SavageJames P. Vaughn Original article 02 April 2009 Pages: 1887 - 1896
Dynamic changes of interleukin-8 network along the colorectal adenoma–carcinoma sequence Guanglin CuiAping YuanJon Florholmen Original article 07 April 2009 Pages: 1897 - 1905